Traders should await the official year-end financial results in the upcoming 10-K filing for audited figures. This preliminary cash update provides limited insight but may offer some confidence in the company's near-term liquidity position.
Price Chart
Executive Summary
Palvella Therapeutics, Inc. announced preliminary cash, cash equivalents, and marketable securities of approximately $55.9 million as of December 31, 2025. This figure is unaudited, preliminary, and subject to change upon completion of the company's financial closing procedures. No other financial results or operational metrics were disclosed.
Key Facts
- Company reported preliminary cash, cash equivalents, and marketable securities of $55.9 million as of December 31, 2025
- The financial data is preliminary, unaudited, and has not been reviewed by the company's independent auditors
- The final reported amount may differ materially from this estimate
- No revenue, earnings, guidance, or other operational results were disclosed in this filing
Financial Impact
Approximately $55.9 million in cash and marketable securities (preliminary)
Risk Factors
- The $55.9 million figure is preliminary and may change significantly upon audit
- No information on revenue, expenses, or profitability was provided
- Investors lack context on cash burn rate or runway implications
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-019143 |
| Document: 0001104659-26-019143-index-headers.html | 0001104659-26-019143 |
| Document: 0001104659-26-019143-index.html | 0001104659-26-019143 |
| Document: 0001104659-26-019143.txt | 0001104659-26-019143 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 4w ago | 144 | $155.47 $132.47 | ▼ −14.79% | ▼ −13.61% | $132.47 (−14.79%) |
Aug 9, 2026 7w ago | Institutional Cluster | $152.22 $157.00 | ▲ +3.14% | ▲ +4.05% | $132.47 (−12.97%) |
Aug 4, 2026 8w ago | 8-K | $151.99 $150.55 | ▼ −0.95% | ▲ +0.29% | $132.47 (−12.84%) |
Jul 30, 2026 9w ago | Press Release | $150.19 $150.33 | ▲ +0.09% | ▼ −3.87% | $132.47 (−11.80%) |
Jul 28, 2026 9w ago | Press Release | $142.84 $148.24 | ▲ +3.78% | ▲ +0.40% | $132.47 (−7.26%) |
Jun 30, 2026 13w ago | 8-K | $152.82 $141.77 | ▼ −7.23% | ▼ −6.20% | $132.47 (−13.32%) |
Jun 22, 2026 14w ago | Press Release | $118.84 $157.24 | ▲ +32.31% | ▲ +32.46% | $132.47 (+11.47%) |
Jun 16, 2026 15w ago | 8-K | $110.12 $149.68 | ▲ +35.92% | ▲ +35.72% | $132.47 (+20.30%) |
Jun 11, 2026 16w ago | Institutional Cluster | $106.38 $151.04 | ▲ +41.98% | ▲ +40.09% | $132.47 (+24.53%) |
May 15, 2026 20w ago | 8-K | $114.24 $116.51 | ▲ +1.99% | ▼ −0.13% | $132.47 (+15.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access